---
figid: PMC9019764__etm-23-05-11287-g05
pmcid: PMC9019764
image_filename: etm-23-05-11287-g05.jpg
figure_link: /pmc/articles/PMC9019764/figure/f6-ETM-23-5-11287/
number: Figure 6
figure_title: ''
caption: Optimal conformations between SIN and VEGFR2 are estimated by molecular docking.
  (A) The binding modes of the SIN-VEGFR2 complex with minimum energy. (B) The overall
  interactions between SIN and the protein residues. (C) The optimal binding position
  of SIN with VEGFR2. (D) Representation of the interaction between SIN and VEGFR2.
  SIN, sinensetin; VEGFR, vascular endothelial growth factor receptor.
article_title: Sinensetin suppresses angiogenesis in liver cancer by targeting the
  VEGF/VEGFR2/AKT signaling pathway.
citation: Xiao Li, et al. Exp Ther Med. 2022 May;23(5):360.
year: '2022'

doi: 10.3892/etm.2022.11287
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- sinensetin
- angiogenesis
- liver cancer
- human umbilical vascular endothelial cell
- molecular mechanism

---
